- Home
- NTRB vs FORA Comparison
NTRB vs FORA Comparison
Compare NTRB & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- FORA
- Stock Information
- Founded
- NTRB 2016
- FORA 2014
- Country
- NTRB United States
- FORA United States
- Employees
- NTRB N/A
- FORA N/A
- Industry
- NTRB Industrial Specialties
- FORA Computer Software: Prepackaged Software
- Sector
- NTRB Health Care
- FORA Technology
- Exchange
- NTRB Nasdaq
- FORA Nasdaq
- Market Cap
- NTRB 77.9M
- FORA 63.8M
- IPO Year
- NTRB N/A
- FORA N/A
- Fundamental
- Price
- NTRB $6.17
- FORA $2.10
- Analyst Decision
- NTRB
- FORA Strong Buy
- Analyst Count
- NTRB 0
- FORA 1
- Target Price
- NTRB N/A
- FORA $5.00
- AVG Volume (30 Days)
- NTRB 28.2K
- FORA 14.2K
- Earning Date
- NTRB 12-11-2024
- FORA 11-07-2024
- Dividend Yield
- NTRB N/A
- FORA N/A
- EPS Growth
- NTRB N/A
- FORA N/A
- EPS
- NTRB N/A
- FORA 0.06
- Revenue
- NTRB $1,803,816.00
- FORA $20,371,880.00
- Revenue This Year
- NTRB N/A
- FORA N/A
- Revenue Next Year
- NTRB N/A
- FORA $10.64
- P/E Ratio
- NTRB N/A
- FORA $36.34
- Revenue Growth
- NTRB N/A
- FORA 6.97
- 52 Week Low
- NTRB $1.93
- FORA $2.00
- 52 Week High
- NTRB $9.60
- FORA $4.15
- Technical
- Relative Strength Index (RSI)
- NTRB 50.57
- FORA 38.13
- Support Level
- NTRB $5.24
- FORA $2.05
- Resistance Level
- NTRB $6.40
- FORA $2.16
- Average True Range (ATR)
- NTRB 0.71
- FORA 0.05
- MACD
- NTRB -0.12
- FORA 0.00
- Stochastic Oscillator
- NTRB 33.23
- FORA 31.77
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.